Fengxu Gan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Fengxu Gan has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Jie Lou
School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China
2 shared publications - Xiaofang Zhou
School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China
2 shared publications - Xing Zhou
Yunnan Key Laboratory of Stem Cell and Regenerative Medicine, Rehabilitation School, Kunming Medical University, Kunming, China
2 shared publications - Hongli Duan
School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China
1 shared publication - Jianyu Zheng
School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China
1 shared publication - Junshan Lan
School of Pharmacy and Bioengineering, Chongqing University of Technology, Chongqing 400054, China
1 shared publication
Latest Publications
- Open Access
- 6 January 2025
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 16 (1) , 15
From Blood to Therapy: The Revolutionary Application of Platelets in Cancer-Targeted Drug Delivery
Biomimetic nanodrug delivery systems based on cell membranes have emerged as a promising approach for targeted cancer therapy due to their biocompatibility and low immunogenicity. Among them, platelet-mediated systems are particularly noteworthy for their innate tumor-homing and cancer cell interaction capabilities. These systems utilize nanoparticles shielded and directed by platelet membrane coatings for efficient drug delivery. This review highlights the role of platelets in cancer therapy, summarizes the advancements in platelet-based drug delivery systems, and discusses their integration with other cancer treatments. Additionally, it addresses the limitations and challenges of platelet-mediated drug delivery, offering insights into future developments in this innovative field.
- 6 January 2025
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 16 (1) , 15
Open AccessFrom Blood to Therapy: The Revolutionary Application of Platelets in Cancer-Targeted Drug Delivery
Biomimetic nanodrug delivery systems based on cell membranes have emerged as a promising approach for targeted cancer therapy due to their biocompatibility and low immunogenicity. Among them, platelet-mediated systems are particularly noteworthy for their innate tumor-homing and cancer cell interaction capabilities. These systems utilize nanoparticles shielded and directed by platelet membrane coatings for efficient drug delivery. This review highlights the role of platelets in cancer therapy, summarizes the advancements in platelet-based drug delivery systems, and discusses their integration with other cancer treatments. Additionally, it addresses the limitations and challenges of platelet-mediated drug delivery, offering insights into future developments in this innovative field.
- Top Cited PapersOpen Access
- 1 February 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (2) , 484
Advances in Oral Drug Delivery Systems: Challenges and Opportunities
The oral route is the most preferred route for systemic and local drug delivery. However, the oral drug delivery system faces the harsh physiological and physicochemical environment of the gastrointestinal tract, which limits the bioavailability and targeted design of oral drug delivery system. Innovative pharmaceutical approaches including nanoparticulate formulations, biomimetic drug formulations, and microfabricated devices have been explored to optimize drug targeting and bioavailability. In this review, the anatomical factors, biochemical factors, and physiology factors that influence delivering drug via oral route are discussed and recent advance in conventional and novel oral drug delivery approaches for improving drug bioavailability and targeting ability are highlighted. We also address the challenges and opportunities of oral drug delivery systems in future.
- 1 February 2023
- Published by MDPI AG in Pharmaceutics
- Vol. 15 (2) , 484
Top Cited PapersOpen AccessAdvances in Oral Drug Delivery Systems: Challenges and Opportunities
The oral route is the most preferred route for systemic and local drug delivery. However, the oral drug delivery system faces the harsh physiological and physicochemical environment of the gastrointestinal tract, which limits the bioavailability and targeted design of oral drug delivery system. Innovative pharmaceutical approaches including nanoparticulate formulations, biomimetic drug formulations, and microfabricated devices have been explored to optimize drug targeting and bioavailability. In this review, the anatomical factors, biochemical factors, and physiology factors that influence delivering drug via oral route are discussed and recent advance in conventional and novel oral drug delivery approaches for improving drug bioavailability and targeting ability are highlighted. We also address the challenges and opportunities of oral drug delivery systems in future.